Heart Test Laboratories, Inc.
HSCSHeartSciences Inc. is a medical technology company focused on enhancing the clinical utility of electrocardiograms (ECG) through artificial intelligence.
Earnings
Next report
Sep 10, 2026 (in a month)Competitors
By market cap
By revenue growth
Profile
HeartSciences Inc. is a medical technology company focused on enhancing the clinical utility of electrocardiograms (ECG) through artificial intelligence. The company develops AI-based algorithms designed to detect structural and ischemic heart diseases, such as cardiac dysfunction, which are often missed by conventional ECGs. Its core value proposition lies in providing low-cost, frontline screening tools that bridge the diagnostic gap between standard ECGs and expensive cardiac imaging.
An early-stage innovator seeking to disrupt the traditional ECG market by introducing AI-driven diagnostic capabilities for structural heart disease.
FAQ
- What is Heart Test Laboratories, Inc.'s market cap?
- Heart Test Laboratories, Inc. (HSCS) has a market capitalization of $8.3M and trades on NASDAQ.
- Who are Heart Test Laboratories, Inc.'s competitors?
- Heart Test Laboratories, Inc.'s key competitors include GE Healthcare Technologies, Inc., Koninklijke Philips N.V., Baxter International, Inc., and others. These companies compete in similar markets and product categories.
- Who does Heart Test Laboratories, Inc. partner with?
- Heart Test Laboratories, Inc.'s notable partners include Icahn School of Medicine at Mount Sinai, University of Glasgow, Rutgers, The State University of New Jersey, and others.
- Where is Heart Test Laboratories, Inc. headquartered?
- Heart Test Laboratories, Inc. is headquartered in United States of America and employs approximately 12 people. It has been publicly traded since 2022.